Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,098,486
  • Shares Outstanding, K 43,881
  • Annual Sales, $ 1,628 M
  • Annual Income, $ 589,200 K
  • 60-Month Beta 0.97
  • Price/Sales 2.56
  • Price/Cash Flow 6.61
  • Price/Book 1.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.92
  • Number of Estimates 4
  • High Estimate 3.32
  • Low Estimate 0.47
  • Prior Year 1.48
  • Growth Rate Est. (year over year) +29.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.86 +13.41%
on 10/24/19
95.88 -3.17%
on 11/20/19
+8.58 (+10.18%)
since 10/22/19
3-Month
76.33 +21.63%
on 10/04/19
95.88 -3.17%
on 11/20/19
+9.99 (+12.06%)
since 08/22/19
52-Week
74.31 +24.94%
on 07/23/19
128.94 -28.00%
on 03/01/19
-21.38 (-18.72%)
since 11/21/18

Most Recent Stories

More News
United Therapeut Rises 1.07% on Heavy Volume: Watch For Potential Pullback

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $90.14 to a high of $91.81. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high...

UTHR : 92.52 (-0.94%)
Correvio Reports Third Quarter 2019 Financial Results

NASDAQ: CORV TSX: CORV

CORV : 2.19 (-0.45%)
CORV.TO : 2.89 (-1.03%)
UTHR : 92.52 (-0.94%)
MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics

MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for...

UTHR : 92.52 (-0.94%)
MNKD : 1.16 (-1.69%)
United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up

United Therapeutics (UTHR) beats estimates on both fronts in the third quarter. Stock rises in response

LLY : 115.77 (+0.89%)
MDT : 111.09 (+0.54%)
ARNA : 46.32 (-1.24%)
UTHR : 92.52 (-0.94%)
Will United Therapeutics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor United Therapeutics.

UTHR : 92.52 (-0.94%)
Watch for United Therapeut to Potentially Pullback After Gaining 14.47% Yesterday

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $89.44 to a high of $95.76. Yesterday, the shares gained 14.5%, which took the trading range above the 3-day high...

UTHR : 92.52 (-0.94%)
SmarTrend Watching for Potential Pullback in Shares of United Therapeut After 14.47% Gain

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $89.44 to a high of $95.76. Yesterday, the shares gained 14.5%, which took the trading range above the 3-day high...

UTHR : 92.52 (-0.94%)
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial

Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial

CMRE : 8.02 (-1.47%)
FAF : 62.50 (-0.35%)
UTHR : 92.52 (-0.94%)
INTC : 57.77 (-0.77%)
PLXS : 75.87 (-1.28%)
United Therapeutics (UTHR) Tops Q3 Earnings and Revenue Estimates

United Therapeutics (UTHR) delivered earnings and revenue surprises of 28.63% and 19.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

UTHR : 92.52 (-0.94%)
United Therapeutics: 3Q Earnings Snapshot

SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported third-quarter profit of $132.4 million.

UTHR : 92.52 (-0.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

The current trending strength of the market is Weak.

See More Share

Trade UTHR with:

Business Summary

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability....

See More

Key Turning Points

2nd Resistance Point 96.14
1st Resistance Point 94.77
Last Price 92.52
1st Support Level 92.30
2nd Support Level 91.20

See More

52-Week High 128.94
Fibonacci 61.8% 108.07
Fibonacci 50% 101.63
Fibonacci 38.2% 95.18
Last Price 92.52
52-Week Low 74.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar